Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 111,871 | 79,356 | 18,215 | 0 | 0 |
| Gross Profit | 111,871 | 79,356 | 18,215 | N/A | N/A |
| Operating Expenses | 559,645 | 334,960 | 262,315 | 232,758 | 51,678 |
| Operating Income | -447,774 | -255,604 | -244,100 | -232,758 | -51,678 |
| Other Income | 4,667 | -633 | 1,964 | -10,649 | -142 |
| Pre-tax Income | -443,107 | -256,237 | -242,136 | -243,407 | -51,820 |
| Income Tax | -6,001 | -10,657 | -2,760 | N/A | N/A |
| Net Income Continuous | -437,106 | -245,580 | -239,376 | -243,407 | -51,820 |
| Net Income | $-437,106 | $-245,580 | $-239,376 | $-243,407 | $-51,820 |
| EPS Basic Total Ops | -4.10 | -2.42 | -2.72 | -36.82 | -14.16 |
| EPS Basic Continuous Ops | -4.10 | -2.42 | -2.72 | -28.83 | -14.16 |
| EPS Diluted Total Ops | -4.10 | -2.42 | -2.72 | -36.82 | -14.16 |
| EPS Diluted Continuous Ops | -4.10 | -2.42 | -2.72 | -28.83 | -14.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.69 | -1.79 | -7.54 | N/A |
| EBITDA(a) | $-424,142 | $-241,418 | $-238,059 | $-232,363 | $-51,676 |